Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Clinical Nuclear Medicine
|
July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET
Olivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation
Antje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
Johannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Cancers
|
April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Theranostics
|
August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
Constantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Cancers
|
August 23, 2020
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
Xiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Clinical Nuclear Medicine
|
July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET
Olivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation
Antje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
Johannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Annals of Clinical and Translational Neurology
|
September 15, 2017
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
Joachim Brumberg, Sebastian Küsters, Ehab Al-Momani, et al.
Cancers
|
April 29, 2020
<sup>18</sup>F-FDG and <sup>11</sup>C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
Maria I Morales-Lozano, Oliver Viering, Samuel Samnick, et al.
Molecular Imaging and Biology
|
August 1, 2024
Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma
Rudolf A Werner, Yingjun Zhi, Niklas Dreher, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 20, 2023
[<sup>18</sup>F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Olivia Kertels, Jürgen Krauß, Camelia Maria Monoranu, et al.
Theranostics
|
August 22, 2017
<sup>11</sup>C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
Constantin Lapa, Maria J Garcia-Velloso, Katharina Lückerath, et al.
Cancers
|
August 23, 2020
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
Xiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Clinical Nuclear Medicine
|
March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel, Markus Krebs, Bülent Polat, et al.
Page
of 10